Suchergebnisse - "Tuberculosis, Meningeal"

PubPharm (2.519)

1

Linezolid Population Pharmacokinetic Model in Plasma and Cerebrospinal Fluid Among Patients With Tuberculosis Meningitis

enthalten in: The Journal of infectious diseases | 2024

von Abdelgawad, N. | Wasserman, S. | Abdelwahab, M. | +7

UpdateOf: medRxiv. 2023 Apr 07;:. - PMID 37066148

2

Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis : A Randomized Double Blind Placebo Controlled Non-inferiority Trial of Adjunctive Dexamethasone for the Treatment of HIV-uninfected Adults With Tuberculous Meningitis Stratified by Leukotriene A4 Hydrolase Genotype

enthalten in: ClinicalTrials.gov | 2024

3

Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial) : A Randomized Double Blind Placebo Controlled Trial of Adjunctive Dexamethasone for the Treatment of HIV-infected Adults With Tuberculous Meningitis

enthalten in: ClinicalTrials.gov | 2024

4

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis : A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis: Improved Management With Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)

enthalten in: ClinicalTrials.gov | 2024

5

Adjunctive Linezolid for the Treatment of Tuberculous Meningitis : Pharmacokinetics and Tolerability of Adjunctive Linezolid for the Treatment of Tuberculous Meningitis

enthalten in: ClinicalTrials.gov | 2024

6

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis : A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis: Improved Management With Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)

enthalten in: ClinicalTrials.gov | 2024

7

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis : Intensified Tuberculosis Treatment to Reduce the Mortality of HIV-infected and Uninfected Patients With Tuberculosis Meningitis: a Phase III Randomized Controlled Trial (Acronym: INTENSE-TBM)

enthalten in: ClinicalTrials.gov | 2024

8

Heparin Binding Protein in Early Differential Diagnosis of Bacterial Meningitis

enthalten in: Indian journal of clinical biochemistry : IJCB | 2024

von Namiduru, E. | Namiduru, M. | Karaoğlan, �. | +1

9

Tuberculous Meningitis : An Endemic Cause of Intracranial Hypertension

enthalten in: Cureus | 2024

von Costa, M. | Caria, J. | Caiano, J. | +2

10

Tuberculous Meningitis: an Update on the Pathogenesis and Neuroimmunology

enthalten in: Current tropical medicine reports | 2024

von Hokeness, S. | Lanni, F. | Glycenfer, J. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[252]